BACKGROUND: There is uncertainty around the optimal surveillance of head and neck cancer patients after the primary curative treatment. This study aims at assessing the cost-effectiveness of a post-treatment programme of frequent radiological assessments (maximal approach) compared with a symptom-driven surveillance (minimal approach). MATERIALS AND METHODS: A decision-analytic Markov model is developed to assess the cost utility of two alternative follow-up programmes with a lifetime horizon. The two interventions differ in the number of radiological assessments (i.e. magnetic resonance imaging, computed tomography and positron-emission tomography) performed over a 5-year period. Clinical and utility parameters are derived from published ...
BACKGROUND: Although surgery and radiation are effective treatments of regional lymphatics for class...
OBJECTIVES: To assess the cost-effectiveness of five strategies for diagnosing and treating cT1-2N0 ...
Objectives: A phase III randomized trial that compared the combination of cetuximab and radiotherapy...
BACKGROUND: There is uncertainty around the optimal surveillance of head and neck cancer patients af...
Background: There is uncertainty around the optimal surveillance of head and neck cancer patients af...
Background: There is uncertainty around the optimal surveillance of head and neck cancer patients af...
BACKGROUND: There is uncertainty around the optimal surveillance of head and neck cancer patients af...
BACKGROUND: A possible surveillance model for patients with head and neck cancer (HNC) who received ...
BACKGROUND: The current study was performed to assess the efficacy of surveillance imaging in patien...
OBJECTIVE: To undertake a cost-effectiveness analysis that compares positron emission tomography - ...
Background: Despite controversy, planned neck dissection (ND) remains standard treatment for patient...
Background: A recent large UK clinical trial demonstrated that positron-emission tomography–computed...
Background: Concomitant chemo-radiotherapy (CCRT) has become an indispensable organ, but not always ...
BACKGROUND: Considerable variation exists in diagnostic tests used for local response evaluation aft...
Abstract Background Considerable variation exists in diagnostic tests used for local response evalua...
BACKGROUND: Although surgery and radiation are effective treatments of regional lymphatics for class...
OBJECTIVES: To assess the cost-effectiveness of five strategies for diagnosing and treating cT1-2N0 ...
Objectives: A phase III randomized trial that compared the combination of cetuximab and radiotherapy...
BACKGROUND: There is uncertainty around the optimal surveillance of head and neck cancer patients af...
Background: There is uncertainty around the optimal surveillance of head and neck cancer patients af...
Background: There is uncertainty around the optimal surveillance of head and neck cancer patients af...
BACKGROUND: There is uncertainty around the optimal surveillance of head and neck cancer patients af...
BACKGROUND: A possible surveillance model for patients with head and neck cancer (HNC) who received ...
BACKGROUND: The current study was performed to assess the efficacy of surveillance imaging in patien...
OBJECTIVE: To undertake a cost-effectiveness analysis that compares positron emission tomography - ...
Background: Despite controversy, planned neck dissection (ND) remains standard treatment for patient...
Background: A recent large UK clinical trial demonstrated that positron-emission tomography–computed...
Background: Concomitant chemo-radiotherapy (CCRT) has become an indispensable organ, but not always ...
BACKGROUND: Considerable variation exists in diagnostic tests used for local response evaluation aft...
Abstract Background Considerable variation exists in diagnostic tests used for local response evalua...
BACKGROUND: Although surgery and radiation are effective treatments of regional lymphatics for class...
OBJECTIVES: To assess the cost-effectiveness of five strategies for diagnosing and treating cT1-2N0 ...
Objectives: A phase III randomized trial that compared the combination of cetuximab and radiotherapy...